OpenVSafe by OpenVAERS
Search V-safe

5KQ-56695-92473

1 vaccination 2 coded responses 4 check-ins 2 free-text entries 3 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
281 / NC
Registered
2021-04-17
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-17
    Registered in v-safe
  2. 2021-04-17
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-17
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  4. 2021-04-19
    Survey response — days 1–6 daily, dose 1
    MedDRA: Chest pain — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Slight chest pain near diaphragm
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-04-19
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  6. 2021-04-20
    Survey response — days 1–6 daily, dose 1
    MedDRA: Nasopharyngitis — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Cold symptoms
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-04-20
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  8. 2021-04-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Adult check-in
  9. 2021-04-21
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  10. 2021-04-23
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-04-17Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-04-19 priority 2/3
2021-04-20 priority 2/3
2021-04-21 Successful
2021-04-23
Participant prefers to complete VAERS report online

Free text

Release 7 — days 1–6 daily, dose 1

2021-04-19

Systemic reaction (other): Slight chest pain near diaphragm

2021-04-20

Systemic reaction (other): Cold symptoms

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROChest pain ✓ ✓ ✓
SRONasopharyngitis ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release